Ahead of the European Parliament’s vote on the use of GMOs, Nathalie Moll calls for a shift to a more coherent and science-based approach to EU policymaking.
Fundamental and accelerating changes in the Arctic are bringing new challenges and opportunities, writes Jardar Jensen.
The European citizens' initiative is at risk of being undermined by several amendments, argues Gerald Häfner.
MEPs must help end the current lack of transparency, accountability and sustainability in EU external fisheries rules, argues Lasse Gustavsson.
Who is controlling the counter-narratives to extremism? This is the question that many EU policymakers want answered, argues Tehmina Kazi.
EU leaders need to implement a more comprehensive disability approach within the EU legislative framework, argues Luk Zelderloo.
Cancer is a global scourge requiring a global solution, say ESMO's Fortunato Ciardiello and Alexandru Eniu.
Secularism, as a bulwark to radicalisation, should be a key EU foreign policy priority, argues the European Foundation for Democracy's Tommaso Virgili.
Chinese companies have become the fastest growing source of foreign investment in Europe, writes Victor Zhang.
The EU and member states have not fully implemented the principles of the UN convention, argues Luk Zelderloo.
The European commission must ensure that social media companies will respect national laws against incitement to religious hatred and violence, says Roberta Bonazzi.
Liquefied petroleum gas can reach isolated rural communities and benefit millions of people, writes Samuel Maubanc...
All the evidence shows that efficient labour markets actually drive economic growth, says Eurociett's Denis Pennel
Ahead of their annual conference, IFAH-Europe's Roxane Feller explains why a better EU veterinary medicines regulatory framework is needed.
Recent eastern partnership summit tainted by ambiguity over EU's Caspian partner, argues Azerbaijani parliament member Azay Guliyev.
What is the best way to address societal and political concerns about the impact of pharmaceuticals on the environment? IFAH-Europe's...
There's overwhelming evidence supporting a limit on industrially produced ...
Commission's plans for harmonising veterinary medicine authorisation need review, argues IFAH-Europe's ...
Europe's single market is hampered by a lack of harmonisation in cross-border delivery rules, argues Jaap Mulders of the European Express Association.
The EU's new clinical trials regulation still has a few implementation challenges to overcome, says Prof. Christian Dittrich.